My Companies
Notification
Account
Log Out
Back

Corona Remedies Starts Commercial Production at EU-GMP Hormone Facility

30 June 2026
CORONA Remedies Ltd.

CORONA Remedies commenced commercial production at its EU-GMP Women's Hormone facility (194M tablets/capsules, 1.5M ointments/gels p.a.), lifting in-house hormone capacity ~20%.

Recent Events

19 June 2026

Sepia Investments and Allies Sell 7.5% Stake in Corona Remedies

Real time WhatsApp alerts using AI.

Get features of

  • Instant Notifications
  • Competitive Advantage
  • Critical Alerts
Signup or Sign in

Company Information